- Fauci: Senators vote to hold former US health chief in contempt for refusing to answer questions. [Journal Article]BMJ. 2026 Aug 07; 394:e100527.BMJ
- Publisher Full Text (DOI)
- Diabetes advocacy campaigns should focus on living a life, not fighting a battle. [Editorial]BMJ. 2026 Aug 07; 394:e100525.BMJ
- Publisher Full Text (DOI)
- "Cockroach" victory: India's education minister resigns over medical exam scandal linked to 12 suicides. [Journal Article]BMJ. 2026 Aug 07; 394:e100429.BMJ
- Publisher Full Text (DOI)
- Fauci's Senate hearing riled up the MAGA base-but at the cost of damaging public health. [Editorial]BMJ. 2026 Aug 07; 394:e100529.BMJ
- Publisher Full Text (DOI)
- Cosmetic surgery: Keep promise to stop all doctors carrying out procedures, campaigners say. [Journal Article]BMJ. 2026 Aug 07; 394:e100528.BMJ
- Publisher Full Text (DOI)
- When I use a word . . . Alumni of the Edinburgh Medical School 1726-2026: The Darwins. [Journal Article]BMJ. 2026 Aug 07; 394:e100521.BMJ
- Publisher Full Text (DOI)
- Population impact matters when evaluating calcium and vitamin D supplementation. [Letter]BMJ. 2026 Aug 07; 394:e100495.BMJ
- Publisher Full Text (DOI)
- Retatrutide: Obesity drug opens to "compassionate use" in US after speculation Trump took it. [Journal Article]BMJ. 2026 Aug 07; 394:e100530.BMJ
- Publisher Full Text (DOI)
- A girl with a fingertip blister. [Journal Article]BMJ. 2026 Aug 06; 394:e100223.BMJ
- Publisher Full Text (DOI)
- Closing the evidence gap when randomised trials are not feasible. [Journal Article]BMJ. 2026 Aug 06; 394:e100509.BMJ
- Publisher Full Text (DOI)
- Tuberculosis treatment support using digital adherence technology. [Editorial]BMJ. 2026 Aug 06; 394:e100492.BMJ
- Publisher Full Text (DOI)
- Erica Schwartz: Trump nominee voted to head CDC. [Journal Article]BMJ. 2026 Aug 06; 394:e100520.BMJ
- Publisher Full Text (DOI)
- The value of knowledge . . . and other research. [Editorial]BMJ. 2026 Aug 06; 394:e100405.BMJ
- Publisher Full Text (DOI)
- Moderna mRNA flu jab at centre of row with FDA gets approval. [Journal Article]BMJ. 2026 Aug 06; 394:e100524.BMJ
- Publisher Full Text (DOI)
- Evaluation of patient centred digital adherence technology for tuberculosis treatment outcomes: pragmatic randomised controlled trial. [Randomized Controlled Trial]BMJ. 2026 Aug 06; 394:e100195.BMJ
- CONCLUSIONS: A multifaceted, interactive digital adherence tool improved tuberculosis treatment outcomes, particularly among younger participants and women, showing feasibility and effectiveness in supporting adherence to tuberculosis treatment in low resource settings. Future research should evaluate the impact of app engagement, context factors such as the covid-19 pandemic, cost effectiveness, and use of the tool beyond tuberculosis in the management of chronic diseases. AI powered features and integrated mental health support may enhance the scalability and personalisation of care.
- Publisher Full Text (DOI)